This company has been marked as potentially delisted and may not be actively trading. Flex Pharma (FLKS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock FLKS vs. GANX, SKYE, ACET, IMMX, RENB, FBIO, VRCA, PEPG, CUE, and ATNMShould you be buying Flex Pharma stock or one of its competitors? The main competitors of Flex Pharma include Gain Therapeutics (GANX), Skye Bioscience (SKYE), Adicet Bio (ACET), Immix Biopharma (IMMX), Renovaro (RENB), Fortress Biotech (FBIO), Verrica Pharmaceuticals (VRCA), PepGen (PEPG), Cue Biopharma (CUE), and Actinium Pharmaceuticals (ATNM). These companies are all part of the "medical" sector. Flex Pharma vs. Gain Therapeutics Skye Bioscience Adicet Bio Immix Biopharma Renovaro Fortress Biotech Verrica Pharmaceuticals PepGen Cue Biopharma Actinium Pharmaceuticals Gain Therapeutics (NASDAQ:GANX) and Flex Pharma (NASDAQ:FLKS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, community ranking, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability. Which has more risk & volatility, GANX or FLKS? Gain Therapeutics has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500. Comparatively, Flex Pharma has a beta of 1.65, meaning that its stock price is 65% more volatile than the S&P 500. Does the MarketBeat Community prefer GANX or FLKS? Flex Pharma received 322 more outperform votes than Gain Therapeutics when rated by MarketBeat users. However, 73.58% of users gave Gain Therapeutics an outperform vote while only 73.23% of users gave Flex Pharma an outperform vote. CompanyUnderperformOutperformGain TherapeuticsOutperform Votes3973.58% Underperform Votes1426.42% Flex PharmaOutperform Votes36173.23% Underperform Votes13226.77% Which has better valuation & earnings, GANX or FLKS? Flex Pharma has higher revenue and earnings than Gain Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGain Therapeutics$50K1,052.26-$22.27M-$0.86-2.07Flex Pharma$840K16.73-$21.92MN/AN/A Do insiders and institutionals hold more shares of GANX or FLKS? 12.0% of Gain Therapeutics shares are held by institutional investors. Comparatively, 14.4% of Flex Pharma shares are held by institutional investors. 7.2% of Gain Therapeutics shares are held by company insiders. Comparatively, 7.6% of Flex Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to GANX or FLKS? In the previous week, Gain Therapeutics had 16 more articles in the media than Flex Pharma. MarketBeat recorded 16 mentions for Gain Therapeutics and 0 mentions for Flex Pharma. Gain Therapeutics' average media sentiment score of 0.71 beat Flex Pharma's score of 0.00 indicating that Gain Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Gain Therapeutics Positive Flex Pharma Neutral Is GANX or FLKS more profitable? Gain Therapeutics has a net margin of 0.00% compared to Flex Pharma's net margin of -1,208.42%. Flex Pharma's return on equity of -98.04% beat Gain Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Gain TherapeuticsN/A -203.91% -128.05% Flex Pharma -1,208.42%-98.04%-83.37% Do analysts rate GANX or FLKS? Gain Therapeutics presently has a consensus target price of $8.20, indicating a potential upside of 360.67%. Given Gain Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Gain Therapeutics is more favorable than Flex Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gain Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17Flex Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryGain Therapeutics beats Flex Pharma on 9 of the 17 factors compared between the two stocks. Get Flex Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLKS vs. The Competition Export to ExcelMetricFlex PharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.05M$6.47B$5.31B$8.28BDividend YieldN/A2.64%5.20%4.10%P/E RatioN/A8.9026.7319.58Price / Sales16.73257.08387.44119.65Price / CashN/A65.8538.2534.62Price / Book1.526.406.744.47Net Income-$21.92M$143.98M$3.23B$248.22M Flex Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLKSFlex PharmaN/A$0.78-0.3%N/A+58.6%$14.05M$840,000.000.004GANXGain Therapeutics1.966 of 5 stars$1.93+0.5%$8.20+324.9%-26.1%$56.79M$50,000.00-1.7520News CoverageAnalyst RevisionSKYESkye Bioscience1.1081 of 5 stars$1.94+12.1%$16.60+755.7%-82.7%$56.07MN/A-2.5211Analyst ForecastACETAdicet Bio2.5644 of 5 stars$0.67-7.4%$7.50+1,022.8%-55.9%$55.25M$24.99M-0.3990IMMXImmix Biopharma1.936 of 5 stars$1.98-5.3%$7.00+253.5%+12.1%$55.11MN/A-2.339News CoverageGap DownRENBRenovaro0.8177 of 5 stars$0.34+3.7%N/A-64.5%$53.20MN/A-0.3620News CoverageGap UpHigh Trading VolumeFBIOFortress Biotech1.7022 of 5 stars$1.74+5.5%$21.00+1,106.9%-7.5%$51.45M$57.68M-0.57170News CoverageAnalyst RevisionVRCAVerrica Pharmaceuticals4.2285 of 5 stars$0.55+8.6%$9.50+1,627.3%-93.1%$50.85M$7.57M-0.3040News CoverageAnalyst UpgradeGap DownPEPGPepGen2.9109 of 5 stars$1.53+1.3%$9.67+531.8%-89.5%$50.06MN/A-0.5130Gap DownCUECue Biopharma3.8678 of 5 stars$0.77+2.3%$3.00+290.7%-63.0%$47.47M$9.29M-0.8560ATNMActinium Pharmaceuticals1.1845 of 5 stars$1.52-1.9%$4.00+163.2%N/A$47.42M$81,000.00-1.0930Trending NewsGap Down Related Companies and Tools Related Companies Gain Therapeutics Competitors Skye Bioscience Competitors Adicet Bio Competitors Immix Biopharma Competitors Renovaro Competitors Fortress Biotech Competitors Verrica Pharmaceuticals Competitors PepGen Competitors Cue Biopharma Competitors Actinium Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLKS) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLKS Stock Free FLKS Stock Alerts